Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Atmo, Baird, Glympse, Medtronic, Sunbird, T2 Biosystems.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Accuray, Motus GI Holdings, Nevro.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aleta, Aspen, Biophytis, Lisata, Novartis, NS, Puma.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Baxter, Celmatix, Dice, Eli Lilly, Gilead, Precigen, Resolutionrx, Respirerx, Salarius, Stealth, Takeda.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aim, Algernon, Bioxytran, Bright Minds, Cocrystal, Halia, Lexicon, Maia, Meissa, Monopar, Nasus, Nervgen, Novo Nordisk, Oculis, Palatin, Praxis, Telix, Urogen, Viracta.

Biopharmas raising money in public or private financings, including: Adarx, Benitec, Georgiamune, Mirati, Nuexone, Protagonist.

New hires and promotions in the biopharma industry, including: Antion, Deciphera, Mirati, Oncopeptides, Sixfold, X4, Xenon.

New hires and promotions in the med-tech industry, including: Nyra Medical, Quanterix, Singular Genomics.

Med-tech firms raising money in public or private financings, including: Diality, Invo Bioscience, Neuraxis.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: C2N Diagnostics.